SLCO3A1 expression is a major determinant of atazanavir PBMC penetration in HIV-infected patients

Por Siccardi, M, D'Avolio, A, Baietto, L, Simiele, M, Bonora, S, Back, DJ, Di Perri, G, Owen, A
Publicado em 2010

A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load

Por Calcagno, A, Milia, MG, D'Avolio, A, Ndayishimiyae, P, Dusabimana, P, Bonora, S, Cusato, J, Simiele, M, Rostagno, R, Siccardi, M, Audagnotto, S, Ghisetti, V, Di Perri, G
Publicado em 2010

Tenofovir Plasma Concentrations According to Companion Drugs: a Cross-Sectional Study of HIV-Positive Patients with Normal Renal Function

Por Calcagno, A., Gonzalez de Requena, D., Simiele, M., D'Avolio, A., Tettoni, M. C., Salassa, B., Orofino, G., Bramato, C., Libanore, V., Motta, I., Bigliano, P., Orsucci, E., Di Perri, G., Bonora, S.
Publicado em 2013